ARTICLE | Distillery Therapeutics
Therapeutics: Acyl-CoA synthetase short-chain family member 2 (ACSS2)
February 5, 2015 8:00 AM UTC
Mouse and patient studies suggest inhibiting ACSS2 could help treat cancer. In patient breast tumor samples, elevated ACSS2 levels were associated with advanced tumor stage and poor survival. In mouse...